HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Interaction of impaired coronary flow reserve and cardiomyocyte injury on adverse cardiovascular outcomes in patients without overt coronary artery disease.

AbstractBACKGROUND:
Minimally elevated serum cardiac troponin reflects myocardial injury and is associated with increased mortality, even absent coronary artery disease (CAD). We sought to investigate the relationship between low-level troponin elevation and impaired coronary flow reserve (CFR), an integrated measure of coronary vasomotor function, and to assess their contributions to adverse outcomes in patients without overt CAD.
METHODS AND RESULTS:
Consecutive patients (n=761) undergoing evaluation for suspected CAD with troponin before stress myocardial perfusion positron emission tomography were followed up (median, 2.8 years) for major adverse cardiovascular events, including cardiovascular death, nonfatal myocardial infarction, or late revascularization. Patients with flow-limiting CAD, left ventricular ejection fraction <40%, or revascularization within 60 days of imaging were excluded. CFR was quantified from stress/rest myocardial blood flow with the use of positron emission tomography. Compared with patients with negative troponin, those with at least 1 positive troponin (n=97) had higher pretest clinical scores, more renal dysfunction, and lower left ventricular ejection fraction and CFR. In adjusted analysis, impaired CFR remained independently associated with positive troponin (odds ratio, 2.18; 95% confidence interval, 1.37-3.47; P=0.001), and both impaired CFR and positive troponin were independently associated with major adverse cardiovascular events (hazard ratio, 2.25; 95% confidence interval, 1.31-3.86; P=0.003; and hazard ratio, 2.42; 95% confidence interval, 1.34-4.40; P=0.004, respectively). Impaired CFR and positive troponin identified patients at highest risk of major adverse cardiovascular events (log-rank P<0.0001), with a significant interaction (P<0.007) seen between CFR and troponin.
CONCLUSIONS:
In patients without overt CAD, impaired CFR was independently associated with minimally elevated troponin and major adverse cardiovascular events. Impaired CFR, here reflecting microvascular dysfunction, modified the effect of a positive troponin on adverse outcomes.
AuthorsViviany R Taqueti, Brendan M Everett, Venkatesh L Murthy, Mariya Gaber, Courtney R Foster, Jon Hainer, Ron Blankstein, Sharmila Dorbala, Marcelo F Di Carli
JournalCirculation (Circulation) Vol. 131 Issue 6 Pg. 528-35 (Feb 10 2015) ISSN: 1524-4539 [Electronic] United States
PMID25480813 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
Copyright© 2014 American Heart Association, Inc.
Chemical References
  • Biomarkers
  • Troponin
Topics
  • Aged
  • Biomarkers (blood)
  • Cardiovascular Diseases (epidemiology)
  • Comorbidity
  • Coronary Artery Disease (blood, diagnosis, epidemiology, physiopathology)
  • Disease-Free Survival
  • Female
  • Follow-Up Studies
  • Fractional Flow Reserve, Myocardial
  • Humans
  • Incidence
  • Logistic Models
  • Male
  • Middle Aged
  • Myocardial Infarction (diagnosis, epidemiology)
  • Myocardial Revascularization
  • Proportional Hazards Models
  • Risk Assessment
  • Stroke Volume
  • Treatment Outcome
  • Troponin (blood)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: